politics · Thursday, May 28, 2026 · 4 min
Don't chase CME at $277.42: federal regulators are building a moat around prediction markets
The federal regulator that oversees futures filed two major prediction markets actions on the same day, the first insider trading case ever brought on event contracts and a second lawsuit to block a state from interfering. CME Group is the obvious incumbent winner, but at $277.42 the stock is breaking down on its chart and the cleaner setup is below $262.
Your guide reads 50+ feeds so you do not have to. Every post is drafted by Nivéstor’s research engine, which queries Claude (Anthropic) across prediction markets, government filings, on-chain data, hedge-fund moves, and more, then renders the result against a fixed editorial template. No human edits the draft before publication. Methodology · Track record.
Watch $262.00: Within 2% of the 52-week low at $257.17, the level where the stock has held twice in the last 6 months
Watch $257.17: Exact 52-week low; a clean re-test would let buyers anchor risk to a defined level
Why this size: No position today. The fundamental story (federal regulator legitimizing the prediction markets industry) is intact, but CME's chart is below both the 50-day moving average ($293.66) and is sitting on the 200-day moving average ($282.64) with a bearish momentum reading. Capital is better held in cash until the price either reclaims $293 (trend repaired) or comes down to $262 (buy the dip in the structural winner).
When you'd hold this: 2 to 8 weeks, around Sixth Circuit ruling on federal jurisdiction over prediction markets expected within the next 90 days
The federal regulator that oversees futures and prediction markets filed two big actions on the same day yesterday. First, it charged a Google employee with insider trading for betting on prediction market contracts tied to Google search results before the public knew the data1. Second, it sued the state of Rhode Island to block local enforcement against prediction market venues2. The obvious incumbent winner is CME Group, the company that runs the largest federally regulated derivatives exchange, but at $277.42 the stock is sliding the wrong way on its chart and the right thing to do today is wait.
What just happened
Yesterday the Commodity Futures Trading Commission, the agency in Washington that regulates futures contracts and prediction markets, did two things on the same afternoon.
One, it charged an employee at Google with using non-public information about upcoming search-result changes to bet on prediction market contracts about those very results1. This is the first time the agency has ever brought an insider trading case on event-contract betting. In plain English: betting markets on real-world outcomes are now being policed the same way stocks are. The government is treating them like a real, regulated market.
Two, the same agency sued Rhode Island to stop the state from going after prediction market operators in court2. This is the second such lawsuit in nine days; on May 18 it sued Minnesota on the same grounds3. And earlier this month the agency filed a brief in a federal appeals court arguing that only it, not any state, has authority over this industry4. The pattern is unmistakable: the federal regulator is building a legal fortress around prediction markets and aggressively defending it.
So what
Here is the chain.
States have been trying to shut down or restrict prediction market venues like Kalshi and Polymarket. The federal regulator is now saying "no, this is our jurisdiction, hands off." That means venues do not have to fight 50 different state battles. That cuts legal risk and clears the runway for growth.
At the same time, the regulator is enforcing the rules of the road. An insider trading case sends the signal to large institutions that this market is policed and trustworthy. Pension funds and corporate treasuries do not put money into an asset class that feels like a wild west; they need to see a rulebook and someone enforcing it. Yesterday they got both.
Which is why this is good news for the established, federally regulated venues. CME Group already runs the largest federally regulated derivatives exchange in the country, and its FedWatch tool, the one that tells everyone the odds of an upcoming Federal Reserve rate decision, is already an event-contract product in everything but name. The infrastructure CME spent decades building is now the most valuable asset in a market the federal government is actively protecting.
Which is why the obvious move is to buy CME. Except the chart says wait.
What to do about it
Don't buy CME today. The story is real, but the stock dropped 4.4% today to $277.42 and is now sitting right on a line that has held it twice in the last six months at around $282 (the 200-day average). If it breaks that line cleanly on volume, it usually drops another 5% to 7% before finding a buyer. Far better to wait for that to play out and put money in at $262, which is within 2% of the 12-month low, than to catch the falling knife today.
If you must own a prediction markets stock today, Robinhood is the cleanest version of this trade and we called it at $76.23 two weeks ago. It is now $84.84, up 12% in a single day. Do not chase it from here. The risk in standing aside is that CME never sells off and re-rates higher on the regulatory tailwind; in that case we miss this entry and look for the next one.
What we got right (and wrong) before
Two weeks ago we said buy Robinhood at $76.23 on federal regulators clearing the path for its prediction markets business. The stock is now $84.84, up about 11%. That trade worked. Today's CME setup is the next leg of the same thesis but the chart is in the wrong place for a buy.
For the nerds
CME quote: $277.42 down 4.38% on the session, volume 1.95M. RSI 42.28 (neutral band, weakening), MACD -2.41 with signal -1.07 and histogram -1.34 (bearish crossover), SMA50 $293.66, SMA200 $282.64. Price is below the 50-day and sitting on the 200-day. 52-week range $257.17 to $329.16.
HOOD quote: $84.84 up 11.99% on the session, RSI 62.49, MACD histogram turned positive (+0.33), SMA50 $76.39, SMA200 $104.01 (still in downtrend on the long-period average). IBKR quote: $83.11, RSI 48.38, within 6% of 52-week high.
CFTC press release log: 9237-26 (Google employee insider trading on event contracts, 2026-05-27)1, 9238-26 (Rhode Island state enforcement lawsuit, 2026-05-27)2, 9233-26 (Minnesota state law lawsuit, 2026-05-18)3, 9230-26 (Sixth Circuit amicus on exclusive jurisdiction, 2026-05-12)4, 9131-26 (no-action letter on event contract data reporting, 2026-05-12).
Not financial advice. Do your own research.
What we passed on
- $HOODPENDING+11.2% since pass
Already up 12% to $84.84 today on the same prediction markets news; we called this trade at $76.23 two weeks ago and the easy money is now made.
- $IBKRPENDING+4.6% since pass
Within 6% of its 52-week high at $88.44 and its momentum has rolled over in the last two weeks; not the spot to add new money.
- $GOOGLPENDING-2.5% since pass
The insider trading case names a Google employee, so the company is on the wrong side of the headline; not a buy on this story.